
Kodiak Sciences Inc: shareholders and insiders
Price
$97.17
November 20, 2026Market cap $6.4B
What Ploutos Investor adds for Kodiak Sciences
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from 2016
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- A figure that did not match the numbers it is built from has been left out.
Insiders and their shares
Purchases and sales by officers and directors from Nov 22, 2025 to Nov 6, 2026, from their own Form 4 filings.
Bought on the market
$241M
2 people
Sold on the market
$4.9M
1 person
From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan100%
- The rest0%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $181M by 4 people·sold $4.9M by 1 person
- 2025: bought $60M by 1 person, no sales
- 2026: bought $181M by 4 people, sold $4.9M by 1 person
- Nov 5, 2026Baker Bros. Advisors LpDirectorKind
- Nov 5, 2026Baker Bros. Advisors LpDirectorKind
- Nov 4, 2026Baker Bros. Advisors LpDirectorKind
- Nov 4, 2026Baker Bros. Advisors LpDirectorKind
- Oct 23, 2026Taiyin YangDirectorKind
- Oct 21, 2026John A. BorgesonChief Financial OfficerKind10b5-1
- Oct 21, 2026John A. BorgesonChief Financial OfficerKind10b5-1
- Oct 21, 2026John A. BorgesonChief Financial OfficerKind10b5-1
- Oct 21, 2026John A. BorgesonChief Financial OfficerKind10b5-1
- Oct 21, 2026John A. BorgesonChief Financial OfficerKind10b5-1
- Oct 21, 2026John A. BorgesonChief Financial OfficerKind10b5-1
- Oct 21, 2026John A. BorgesonChief Financial OfficerKind10b5-1
- Oct 21, 2026John A. BorgesonChief Financial OfficerKind10b5-1
- Oct 21, 2026John A. BorgesonChief Financial OfficerKind10b5-1
- Sep 29, 2026Baker Bros. Advisors LpDirectorKind
- Sep 29, 2026Baker Bros. Advisors LpDirectorKind
- Sep 29, 2026Baker Bros. Advisors LpDirectorKind
- Sep 29, 2026Baker Bros. Advisors LpDirectorKind
- Sep 29, 2026Baker Bros. Advisors LpDirectorKind
- Sep 29, 2026Baker Bros. Advisors LpDirectorKind
- Sep 28, 2026Baker Bros. Advisors LpDirectorKind
- Sep 28, 2026Baker Bros. Advisors LpDirectorKind
- Sep 28, 2026Baker Bros. Advisors LpDirectorKind
- Sep 28, 2026Baker Bros. Advisors LpDirectorKind
- Sep 28, 2026Baker Bros. Advisors LpDirectorKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Baker Bros. Advisors LpDirector | 4,703 | $98.51 | $463.3K | Form 4 | |
| Nov 5, 2026 | Baker Bros. Advisors LpDirector | 81.7K | $98.51 | $8.1M | Form 4 | |
| Nov 4, 2026 | Baker Bros. Advisors LpDirector | 8,742 | $98.51 | $861.2K | Form 4 | |
| Nov 4, 2026 | Baker Bros. Advisors LpDirector | 151.9K | $98.51 | $15M | Form 4 | |
| Oct 23, 2026 | Taiyin YangDirector | 20.0K | $2.35 | $47.0K | Form 4 | |
| Oct 21, 2026 | John A. BorgesonChief Financial Officer | 10b5-1 | 30.0K | $2.49 | $74.7K | Form 4 |
| Oct 21, 2026 | John A. BorgesonChief Financial Officer | 10b5-1 | 8,514 | $87.67 | $746.4K | Form 4 |
| Oct 21, 2026 | John A. BorgesonChief Financial Officer | 10b5-1 | 1,677 | $89.20 | $149.6K | Form 4 |
| Oct 21, 2026 | John A. BorgesonChief Financial Officer | 10b5-1 | 7,623 | $89.74 | $684.1K | Form 4 |
| Oct 21, 2026 | John A. BorgesonChief Financial Officer | 10b5-1 | 5,101 | $90.98 | $464.1K | Form 4 |
| Oct 21, 2026 | John A. BorgesonChief Financial Officer | 10b5-1 | 2,985 | $91.76 | $273.9K | Form 4 |
| Oct 21, 2026 | John A. BorgesonChief Financial Officer | 10b5-1 | 2,000 | $92.66 | $185.3K | Form 4 |
| Oct 21, 2026 | John A. BorgesonChief Financial Officer | 10b5-1 | 2,000 | $93.71 | $187.4K | Form 4 |
| Oct 21, 2026 | John A. BorgesonChief Financial Officer | 10b5-1 | 100 | $94.91 | $9.5K | Form 4 |
| Sep 29, 2026 | Baker Bros. Advisors LpDirector | 619 | $84.24 | $52.1K | Form 4 | |
| Sep 29, 2026 | Baker Bros. Advisors LpDirector | 10.4K | $84.24 | $874.5K | Form 4 | |
| Sep 29, 2026 | Baker Bros. Advisors LpDirector | 1,195 | $85.40 | $102.1K | Form 4 | |
| Sep 29, 2026 | Baker Bros. Advisors LpDirector | 20.0K | $85.40 | $1.7M | Form 4 | |
| Sep 29, 2026 | Baker Bros. Advisors LpDirector | 84 | $85.89 | $7.2K | Form 4 | |
| Sep 29, 2026 | Baker Bros. Advisors LpDirector | 1,416 | $85.89 | $121.6K | Form 4 | |
| Sep 28, 2026 | Baker Bros. Advisors LpDirector | 186 | $86.72 | $16.1K | Form 4 | |
| Sep 28, 2026 | Baker Bros. Advisors LpDirector | 3,114 | $86.72 | $270.1K | Form 4 | |
| Sep 28, 2026 | Baker Bros. Advisors LpDirector | 957 | $86.81 | $83.1K | Form 4 | |
| Sep 28, 2026 | Baker Bros. Advisors LpDirector | 16.0K | $86.81 | $1.4M | Form 4 | |
| Sep 28, 2026 | Baker Bros. Advisors LpDirector | 3,790 | $86.94 | $329.5K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 5, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by KOD's officers and directors from 2018 up to November 21, 2025, 8 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 3 more, back to 2018
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Baker Bros. Advisors LPwith 3 more personsShare of class35.0%
- D. Victor Perlroth, M.d.Share of class9.90%
- Sirenia Capital Management LPwith 1 more personShare of class5.70%
- BlackRock, Inc.Share of class5.30%
- T. Rowe Price Associates, Inc.Share of class5.20%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Baker Bros. Advisors LPwith 3 more persons | 35.0% | 22.05M | Sep 30, 20262 filings since Dec 19, 2025 | 13D/A | |
| D. Victor Perlroth, M.d. | 9.90% | 6.50M | Feb 17, 20262 filings since Feb 14, 2025 | 13G/A | |
| Sirenia Capital Management LPwith 1 more person | 5.70% | 3.50M | May 15, 2026 | 13G | |
| BlackRock, Inc. | 5.30% | 3.27M | Apr 27, 20262 filings since Apr 29, 2025 | 13G | |
| T. Rowe Price Associates, Inc. | 5.20% | 3.25M | Aug 14, 2026 | 13G |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Baker Bros. Advisors LP35.0%From the filing of Sep 30, 2026
Item 4 of Schedule 13D is supplemented and amended, as the case may be, as follows: The disclosures in Item 5 below are incorporated herein by reference. This Amendment No. 12 is being filed to report the acquisition of common stock ("Common Stock") of Kodiak Sciences Inc. (the "Issuer") reported in Item 5(c) that resulted in a more than 1 percent change in beneficial ownership. The disclosure regarding the purchases in Item 5(c) below is incorporated herein by reference. The Funds hold securities of the Issuer for investment purposes. The Reporting Persons or their affiliates may purchase additional securities or dispose of securities in varying amounts and at varying times depending…
From the filing of Sep 30, 2026
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- Point72 Asset Management1.00%Apr 2, 202613G
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter+396%
- Point72 (Cohen)In the quarter
- D.E. ShawIn the quarter-34%
- Renaissance TechnologiesIn the quarter-52%
- Millennium Mgmt (Englander)In the quarter+94%
- AQR CapitalIn the quarter-5.5%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 780.8K | +396% | $74M | 0.04% |
| Point72 (Cohen) | – | – | 0.01% | |
| D.E. Shaw | 139.7K | -34% | $13M | 0.01% |
| Renaissance Technologies | 90.9K | -52% | $8.6M | 0.01% |
| Millennium Mgmt (Englander) | 60.4K | +94% | $5.7M | 0.00% |
| AQR Capital | 64.0K | -5.5% | $6.1M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 13.0% of its shares outstanding were held short, -9.3% since the report before.
- Shares held short
- 8.50M
- 13.0%
- Since the report before9.38M on Sep 30, 2026
- -9.3%
- 4.2
- 2.00M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 51%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 3.35M
- Nov 15, 2023: Shares held short 2.14M
- Nov 30, 2023: Shares held short 1.94M
- Dec 15, 2023: Shares held short 1.58M
- Dec 29, 2023: Shares held short 1.43M
- Jan 12, 2024: Shares held short 1.36M
- Jan 31, 2024: Shares held short 1.57M
- Feb 15, 2024: Shares held short 1.79M
- Feb 29, 2024: Shares held short 1.83M
- Mar 15, 2024: Shares held short 2.02M
- Mar 28, 2024: Shares held short 2.18M
- Apr 15, 2024: Shares held short 2.46M
- Apr 30, 2024: Shares held short 2.60M
- May 15, 2024: Shares held short 2.48M
- May 31, 2024: Shares held short 2.23M
- Jun 14, 2024: Shares held short 2.16M
- Jun 28, 2024: Shares held short 2.14M
- Jul 15, 2024: Shares held short 1.93M
- Jul 31, 2024: Shares held short 1.86M
- Aug 15, 2024: Shares held short 1.74M
- Aug 30, 2024: Shares held short 1.79M
- Sep 13, 2024: Shares held short 1.72M
- Sep 30, 2024: Shares held short 1.54M
- Oct 15, 2024: Shares held short 1.43M
- Oct 31, 2024: Shares held short 1.30M
- Nov 15, 2024: Shares held short 1.35M
- Nov 29, 2024: Shares held short 1.33M
- Dec 13, 2024: Shares held short 1.35M
- Dec 31, 2024: Shares held short 1.46M
- Jan 15, 2025: Shares held short 1.71M
- Jan 31, 2025: Shares held short 2.04M
- Feb 14, 2025: Shares held short 2.05M
- Feb 28, 2025: Shares held short 2.33M
- Mar 14, 2025: Shares held short 2.66M
- Mar 31, 2025: Shares held short 3.19M
- Apr 15, 2025: Shares held short 3.47M
- Apr 30, 2025: Shares held short 3.61M
- May 15, 2025: Shares held short 3.36M
- May 30, 2025: Shares held short 2.28M
- Jun 13, 2025: Shares held short 2.04M
- Jun 30, 2025: Shares held short 2.21M
- Jul 15, 2025: Shares held short 2.49M
- Jul 31, 2025: Shares held short 2.52M
- Aug 15, 2025: Shares held short 2.80M
- Aug 29, 2025: Shares held short 2.91M
- Sep 15, 2025: Shares held short 3.06M
- Sep 30, 2025: Shares held short 3.81M
- Oct 15, 2025: Shares held short 3.80M
- Oct 31, 2025: Shares held short 4.28M
- Nov 14, 2025: Shares held short 4.51M
- Nov 28, 2025: Shares held short 4.82M
- Dec 15, 2025: Shares held short 4.67M
- Dec 31, 2025: Shares held short 6.29M
- Jan 15, 2026: Shares held short 7.13M
- Jan 30, 2026: Shares held short 7.32M
- Feb 13, 2026: Shares held short 6.88M
- Feb 27, 2026: Shares held short 7.05M
- Mar 13, 2026: Shares held short 7.05M
- Mar 31, 2026: Shares held short 9.85M
- Apr 15, 2026: Shares held short 10.32M
- Apr 30, 2026: Shares held short 10.25M
- May 15, 2026: Shares held short 10.20M
- May 29, 2026: Shares held short 10.32M
- Jun 15, 2026: Shares held short 10.48M
- Jun 30, 2026: Shares held short 10.63M
- Jul 15, 2026: Shares held short 10.42M
- Jul 31, 2026: Shares held short 10.23M
- Aug 14, 2026: Shares held short 10.30M
- Aug 31, 2026: Shares held short 10.78M
- Sep 15, 2026: Shares held short 10.67M
- Sep 30, 2026: Shares held short 9.38M
- Oct 15, 2026: Shares held short 8.50M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading55.0% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 55.0% of the shares in the reported trades were short sales, against 59.4% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 55.0%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 59.4%
- Change
- -4.4 pts
- Short sales a dayon average, of 335.4K shares
- 184.5K
- More than atof 3,666 US-listed companies, same days
- 67%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 44.3%
- Oct 15, 2026: Short sales 65.2%
- Oct 16, 2026: Short sales 69.7%
- Oct 19, 2026: Short sales 75%
- Oct 20, 2026: Short sales 63.8%
- Oct 21, 2026: Short sales 50.5%
- Oct 22, 2026: Short sales 66.9%
- Oct 23, 2026: Short sales 73.2%
- Oct 26, 2026: Short sales 60.4%
- Oct 27, 2026: Short sales 53.8%
- Oct 28, 2026: Short sales 65.7%
- Oct 29, 2026: Short sales 54.9%
- Oct 30, 2026: Short sales 56.9%
- Nov 2, 2026: Short sales 56%
- Nov 3, 2026: Short sales 42.3%
- Nov 4, 2026: Short sales 42.2%
- Nov 5, 2026: Short sales 53.4%
- Nov 6, 2026: Short sales 59.9%
- Nov 9, 2026: Short sales 53.4%
- Nov 10, 2026: Short sales 57.9%
- Nov 11, 2026: Short sales 54.4%
- Nov 12, 2026: Short sales 51.7%
- Nov 13, 2026: Short sales 72.6%
- Nov 16, 2026: Short sales 54%
- Nov 17, 2026: Short sales 57.1%
- Nov 18, 2026: Short sales 54.1%
- Nov 19, 2026: Short sales 71.7%
- Nov 20, 2026: Short sales 58.5%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Baker Bros. Advisors LpDirectorDirectly22.11M
- Julian BakerDirector,TenPercentOwnerDirectly–
- Baker Bros. Advisors (GP) LLCDirector,TenPercentOwnerDirectly–
- Baker Brothers Life Sciences LPDirector,TenPercentOwnerDirectly–
- Victor PerlrothChairman and CEODirectly3.68M
- 667, L.p.Director,TenPercentOwnerDirectly–
- John A. BorgesonChief Financial OfficerDirectly211.9K
- Taiyin YangDirectorDirectly20.0K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Baker Bros. Advisors LpDirector | 22.11M | – | Nov 5, 2026 | Form 4 |
| Julian BakerDirector,TenPercentOwner | – | 19.22M | Sep 28, 2026 | Form 4 |
| Baker Bros. Advisors (GP) LLCDirector,TenPercentOwner | – | 18.37M | Sep 28, 2026 | Form 4 |
| Baker Brothers Life Sciences LPDirector,TenPercentOwner | – | 18.36M | Dec 18, 2025 | Form 4 |
| Victor PerlrothChairman and CEO | 3.68M | – | Sep 25, 2026 | Form 4 |
| 667, L.p.Director,TenPercentOwner | – | 1.67M | Sep 29, 2026 | Form 4 |
| John A. BorgesonChief Financial Officer | 211.9K | – | Oct 21, 2026 | Form 4 |
| Taiyin YangDirector | 20.0K | – | Oct 23, 2026 | Form 4 |
A lower bound: it counts only the 8 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- XBIState Street(R) SPDR(R) S&P(R) Biotech ETFWeight in the fund0.54%
- LABUDirexion Daily S&P Biotech Bull 3X SharesWeight in the fund0.43%
- IBBiShares Biotechnology ETFWeight in the fund0.18%
- FESMFidelity Enhanced Small Cap Core ETFWeight in the fund0.11%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.09%
- IWMiShares Russell 2000 ETFWeight in the fund0.05%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.05%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.03%
- VXFVanguard Extended Market Index FundWeight in the fund0.02%
- VHTVanguard Health Care Index FundWeight in the fund0.02%
18 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 121
- Q4 2025: Managers 158
- Q1 2026: Managers 191
- Q2 2026: Managers 200
Institutional investors by quarter
The fund managers holding KOD, quarter by quarter, from Q4 2018 to Q2 2025, 27 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 200 managers held 60.48M shares, worth $2.4B. During the quarter 38 opened a position, 29 closed one, 78 added and 56 trimmed.
The largest holders, Q2 2026
- Baker Bros. AdvisorsIn the quarter
- BlackRockIn the quarter+5.1%
- Price T Rowe AssociatesIn the quarter+59%
- State StreetIn the quarter+7.5%
- Goldman Sachs GroupIn the quarter+37%
- Vanguard Capital ManagementIn the quarter+5.1%
- BraidwellIn the quarter-1.7%
- Jupiter TopcoIn the quarter
- Rtw InvestmentsIn the quarter
- Boxer Capital ManagementIn the quarter+8.6%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Baker Bros. Advisors | 19.92M | $776M | |
| BlackRock | 4.14M | +5.1% | $161M |
| Price T Rowe Associates | 3.25M | +59% | $127M |
| State Street | 2.42M | +7.5% | $94M |
| Goldman Sachs Group | 2.32M | +37% | $90M |
| Vanguard Capital Management | 1.80M | +5.1% | $70M |
| Braidwell | 1.79M | -1.7% | $70M |
| Jupiter Topco | 1.53M | $60M | |
| Rtw Investments | 1.49M | $58M | |
| Boxer Capital Management | 1.48M | +8.6% | $58M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Kodiak Sciences's filings show?
Who buys and sells is one part of Kodiak Sciences's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have KOD's insiders bought or sold?
From Jun 5, 2026 to Nov 6, 2026 Kodiak Sciences's insiders bought $181M and sold $3.7M of shares on the market. 100% of the sales were under set 10b5-1 plans.
Which well-known managers hold KOD?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $74M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.